Sign in
CompletedNo phase

Assessment of Red Cell Distribution Width's Prognostic Ability in Septic Intensive Care Unit Patients

Key facts

Who runs it
Ain Shams University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
60 people enrolled
Started
1 Apr 2024
Ended
14 Sept 2024
Type of study
Observational
Treatments tested
  • Prognostic biomarker as Red Cell Distribution Width
Record updated
7 March 2025

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age Group: all adult patients aged more than 18 Years old and less than 70 years old
  • Intensive care unit admitted patients with sepsis

Who cannot take part

  • Patients with known hematological disease (e.g., leukemia, myelodysplastic syndrome), human immunodeficiency virus (HIV) infection or any immunosuppressant usage history
  • Patients having uncured malignancy
  • Patients who had a cardiac arrest event before ICU arrival
  • Patients less than 18 years old and more than 70 years old
  • Patients who had recent (less than one week) blood transfusion

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Various biomarkers are used for predicting outcome from sepsis and septic shock, but single value doesn't give a clear-cut picture. This prospective observational study aims to approach the prognostic value of Red Cell Distribution Width for morbidity and mortality of intensive care unit patients with sepsis. and this will be achieved by:

Read full original descriptionShow less

* Assessment of prognostic value of red cell distribution width in septic intensive care unit patients for 28 days mortality * Comparison between red cell distribution width and other inflammatory markers as C-reactive protein and serum lactate as well as other scoring systems such as Sequential Organ Failure Assessment (SOFA) score, regarding their prognostic discriminative ability.

Treatments tested

  • Prognostic biomarker as Red Cell Distribution Width

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Red Cell Distribution Width as a Prognostic Factor for Morbidity and Mortality of Intensive Care Unit Patients With Sepsis.
Record updated
7 March 2025